Details mergers and acquisitions, establishment of subsidiaries, grants and funding, and industry lawsuits. Thu, 23 May 2013 09:52:52 -0400 http://genengnews.com/media/files/rss/BIOBUSINESS-inside-industry.xml http://genengnews.com/gen-news-highlights/hhs-gsk-hunt-for-drugs-to-fight-antibiotic-resistance-bioterrorism/81248400/ http://genengnews.com/gen-news-highlights/hhs-gsk-hunt-for-drugs-to-fight-antibiotic-resistance-bioterrorism/81248400/ Wed, 22 May 2013 11:05:00 -0400 http://genengnews.com/gen-news-highlights/fda-cgmp-complaints-draw-boehringer-ingelheim-promise-of-action/81248399/ http://genengnews.com/gen-news-highlights/fda-cgmp-complaints-draw-boehringer-ingelheim-promise-of-action/81248399/ Wed, 22 May 2013 10:47:00 -0400 http://genengnews.com/gen-news-highlights/empire-genomics-nabs-prostate-cancer-biomarker-from-cornell/81248396/ http://genengnews.com/gen-news-highlights/empire-genomics-nabs-prostate-cancer-biomarker-from-cornell/81248396/ Wed, 22 May 2013 10:30:00 -0400 http://genengnews.com/gen-news-highlights/phase-iii-success-for-boehringer-ingelheim-asthma-drug/81248398/ http://genengnews.com/gen-news-highlights/phase-iii-success-for-boehringer-ingelheim-asthma-drug/81248398/ Wed, 22 May 2013 09:59:00 -0400